From: Sequelae due to bacterial meningitis among African children: a systematic literature review
Reference | Country | No. CBM cases with known outcomes | CFR | No. cases assessed for sequelae | HL (%) | VL (%) | CD (%) | BP (%) | MI (%) | SZ (%) | Any neuropsychological sequelae (%) | Bacterial pathogens studied |
---|---|---|---|---|---|---|---|---|---|---|---|---|
[43] | Ethiopia | 32 | 34% | Â | Â | Â | Â | Â | Â | Â | Â | Spn, Hib, Nm, Gram negative enterococci |
[45] | Ethiopia | 124 | 2% | 121 | 3% | Â | Â | Â | Â | Â | 8% | Nm |
[54] | Kenya | 224 | 33% | 150 | Â | Â | Â | Â | Â | Â | 27% | Spn, Hib, non-typhi Salmonella, enterobacteria, Streptococcus group A or B and others |
[62] | Sudan | 108 | 4% | 104 | 3% | Â | Â | Â | 2% | Â | 5% | Nm |
[60] | Sudan | 43 | 19% | 35 | 20% | Â | Â | Â | 11%a | Â | 26% | Spn, Hib, Nm and others |
[38] | Cameroon | 174 | 30% | 121 | Â | Â | Â | Â | Â | Â | 17% | Spn, Hib, Nm, Streptococcus, Staphylococcus, enterobacteria |
[64] | Cameroon | 99 | 9% | 90 | Â | Â | Â | Â | 1%a | 1% | 4% | Spn, Hib, Nm |
[63] | Burkina Faso | 53 | 75% | Â | Â | Â | Â | Â | Â | Â | Â | Salmonella |
[66] | Burkina Faso | 92 | 22% | 72 | Â | Â | Â | Â | 7% | Â | 18% | Hib |
[37] | Cote d'Ivoire | 654 | 41% | 380 | 6% | 1% | Â | Â | 2% | Â | 19% | Spn, Hib |
[53] | Cote d'Ivoire | 47 | 4% | 45 | Â | Â | Â | Â | Â | Â | 7% | Spn, Hib, Nm |
[47] | Ghana | 67 | 27% | 49 | 8% | 2% | Â | Â | 6%a | Â | 12% | Spn, Hib, Nm |
[67] | Mali and Niger | 426 | 37% | 269 | Â | Â | Â | Â | Â | Â | 14% | Spn, Hib, Nm and others |
[55] | Nigeria | 124 | 27% | 91 | Â | Â | Â | Â | Â | Â | 18% | Spn, Hib, Nm and others |
[40] | Senegal | 511 | 18% | 420 | Â | Â | Â | Â | Â | Â | 21% | Spn, Hib, Nm |
[56] | Angola | 403 | 33% | 270 | Â | Â | Â | Â | Â | Â | 24% | Spn, Hib, Nm, others |
[57] | Madagascar | 83 | 31% | 57 | Â | Â | Â | Â | Â | Â | 30% | Spn, Hib, Nm |
[51] | Malawi | 149 | 34% | 92 | Â | Â | Â | Â | Â | Â | 20% | Spn, Hib, Escherichia coli, Klebsiella, Group B Streptococcus, others |
[52] | Malawi | 52 | 54% | Â | Â | Â | Â | Â | Â | Â | Â | Salmonella |
[44] | Gabon | 91 | 31% | 62 | Â | Â | Â | Â | Â | Â | 18% | Spn, Hib, Nm, Salmonella |
[59] | Algeria | 57 | 4% | 55 | 2% | Â | 2% | Â | Â | Â | 4% | Hib |
[16] | Egypt | 160 | 51% | 78 | Â | 8% | Â | Â | 6% | Â | 18% | Tuberculosis |
[34] | Morocco | 118 | 1% | 117 | 9% | 3% | Â | 1% | 2% | 1% | 21% | Nm |
[33] | Morocco | 141 | 9% | 128 | Â | Â | Â | Â | Â | Â | 27% | Spn |
[15] | Tunisia | 73 | 14% | 61 | 7% | 2% | Â | Â | 5% | 3% | 34% | Spn |
[42] | South Africa | 61 | 20% | 49 | 33% | 8% | Â | Â | 37% | Â | 57% | Spn, Hib, Nm, others |
[14] | South Africa | 79 | 30% | 55 | 5% | Â | Â | Â | Â | Â | 38% | Spn |